Seer Inc (SEER)
2.42
+0.10
(+4.40%)
USD |
NASDAQ |
Nov 14, 16:00
2.42
0.00 (0.00%)
After-Hours: 16:50
Seer Total Liabilities (Quarterly): 38.70M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 38.70M |
| June 30, 2024 | 41.91M |
| March 31, 2024 | 38.41M |
| December 31, 2023 | 39.36M |
| September 30, 2023 | 39.17M |
| June 30, 2023 | 43.08M |
| March 31, 2023 | 39.80M |
| December 31, 2022 | 40.94M |
| September 30, 2022 | 42.44M |
| Date | Value |
|---|---|
| June 30, 2022 | 44.26M |
| March 31, 2022 | 40.63M |
| December 31, 2021 | 36.22M |
| September 30, 2021 | 12.64M |
| June 30, 2021 | 11.00M |
| March 31, 2021 | 9.869M |
| December 31, 2020 | 10.71M |
| September 30, 2020 | 8.354M |
| December 31, 2019 | 5.557M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.557M
Minimum
Dec 2019
44.26M
Maximum
Jun 2022
30.17M
Average
38.94M
Median
Total Liabilities (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 179.66M |
| Poseida Therapeutics Inc | 237.87M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.42M |
| Shareholders Equity (Quarterly) | 344.73M |
| Current Ratio | 18.36 |